Bio+Tech18 conference set for Sept. 20 in Baltimore
The Maryland Tech Council is holding a biotechnology conference next week in Baltimore.
Gaithersburg biotech company raises $36 million
Gaithersburg biotech startup Neuraly has raised $36 million for its potential Alzheimer’s disease and Parkinson’s disease treatment, the company announced.
Vaccinogen relocates to Baltimore from Frederick
Vaccinogen Inc. has moved its corporate headquarters to Baltimore to take advantage of the city’s research institutions and biotechnology activity.
NIH partners with Vtesse Inc. to treat rare disease
The National Institutes of Health in Bethesda has partnered with Vtesse Inc., a Gaithersburg-based biotechnology company, to develop treatments for an often-fatal group of disorders known as lysosomal storage diseases.
Biotech awards focus on health care innovation
A state program that supports commercialization of biotechnology research is shifting its focus, and will now favor projects that can help improve health care quality while reducing costs.
Sanaria turns to crowdfunding website
Sanaria Inc., of Rockville, a biotechnology company that is developing an anti-malaria vaccine, said it aims to raise at least $250,000 in 30 days on Indiegogo.com, a crowdfunding website.
Emergent drug gets coveted FDA status
Emergent BioSolutions Inc., of Rockville, which develops and manufactures products that harness the immune system to treat and prevent disease, announced its BioThrax treatment for anthrax disease has been granted orphan drug status by the Food and Drug Administration for people with suspected or confirmed exposure to anthrax.
Germantown-based Intrexon agrees to acquire Medistem
Intrexon Corp., of Germantown, a developer of synthetic biological products targeting health, food, energy and environmental industries, said it has signed a definitive agreement to acquire San Diego-based Medistem Inc., a stem-cell company, in a cash-and-stock deal valued at approximately $26 million. Medistem is a developer of endometrial regenerative cells (ERCs), which are universal donor [&he[...]
Baltimore biotech Gliknik, Pfizer sign accord
Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.
Health IT startups eligible for funds, resources
You get money, a place to work, a mentor and access to resources. The rest is up to you.
UM Ventures announces license deals
University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore, and the University of Maryland, College Park, announced license and/or option agreements with five life sciences companies across the Baltimore-Washington region. The companies are Rexahn Pharmaceuticals Inc., of Rockville; IGI Technologies Inc., of Elkridge; Plasmonix Inc., of Arbu[...]
Ameritox acquires Ga.-based Prium
Ameritox L.P., of Baltimore, a pain medication monitoring provider offering specialized laboratory testing and reporting services for physicians, announced it has acquired Prium, of Duluth, Ga., a provider of medical cost management services for the workers' compensation market.